Skip to main content

Charles M Rice

NIH Rank #960
  • Top 5% Funded
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1891549Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Microbiology & Immunology

NIH Funding · FY2024

Linked Award Amount
$5.5M
Full award amounts, FY2024
Award Records
9
Records listing this PI
Award-Linked Rank
#960
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Charles M Rice. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Charles M Rice as a PI. Multi-PI records show the full award amount for context.

  • 5R01AI124690-08R01
    Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunity
    $846.8K
    award amount
  • 1R01AI183884-01R01
    Breaching the species barrier: Towards an immunocompetent HBV-susceptible mouse model
    $788.2K
    award amount
  • 5R01AI161444-03R01
    Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo
    $650.4K
    award amount
  • 5R01AI175382-02R01
    Employing viruses to unravel the functional significance of the m5C epitranscriptome
    $649.4K
    award amount
  • 5R01AI150275-05R01
    Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology
    $611.1K
    award amount
  • 5R01AI158676-03R01
    A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system
    $610.9K
    award amount
  • 5R01AI169015-03R01
    TMEM41B: a pan-flavivirus and pan-coronavirus host factor with antiviral potential
    $607.3K
    award amount
  • 5R01DK125100-04R01
    A renewable and genetically tractable human stem cell-derived multicellular platform for the study of fibrotic liver diseases
    $476K
    award amount
  • 5R21AI171880-02R21
    Elucidating the mechanism by which ADAR1 prevents autoimmunity against self RNA
    $211.9K
    award amount

Award organization

Organizations that administered FY2024 awards listing Charles M Rice as a PI.

FY2024 award administered by Rockefeller University (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Rockefeller University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #960
  7. 2024
    Entered Top 25% Nationally
    Ranked #960
  8. 2024
    Entered Top 10% Nationally
    Ranked #960
  9. 2024
    Entered Top 5% Nationally
    Ranked #960
  10. 2025
    $10M Cumulative Funding
  11. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Charles M Rice.